Peritoneal carcinomatosis, a condition in which gastrointestinal cancer spreads to the abdominal cavity, can be a devastating diagnosis for patients. However, Dr. Mio Kitano, a surgical oncologist at UT Health San Antonio, specializes in treating such cases and emphasizes that there are various treatment options available for patients at her institution.
Dr. Kitano highlights cytoreductive surgery as one of the main treatments offered at UT Health San Antonio. This procedure involves removing cancerous deposits from the surface of abdominal organs, similar to peeling wallpaper off a wall. The surgery also includes the removal of any dispensable organs with tumor deposits, such as the spleen, small bowel, and large bowel. Additionally, hot chemotherapy is utilized to target any microscopic cells that may remain after the surgery. This comprehensive approach aims to eradicate cancer cells and improve patient outcomes.
As an associate professor in the Department of Surgery and a surgical oncologist at the Mays Cancer Center at UT Health San Antonio, Dr. Kitano is at the forefront of gastrointestinal cancer treatment. Through innovative surgical techniques and personalized care plans, she offers hope to patients facing peritoneal carcinomatosis. The collaborative effort between TPR and The University of Texas Health Science Center at San Antonio showcases the advancements in scientific discovery that are improving medical practices and patient outcomes.
In conclusion, receiving a diagnosis of gastrointestinal cancer can be challenging for patients but with specialized doctors like Dr. Kitano who specialize in treating such cases there are various treatment options available for them.
Dr. Kitano’s expertise in gastrointestinal tumors and malignancies has made her an essential asset to UT Health San Antonio’s efforts to improve patient outcomes for those facing peritoneal carcinomatosis.
The collaborative effort between TPR and The University of Texas Health Science Center at San Antonio highlights how scientific discoveries are transforming medical practices and providing hope for those facing this devastating diagnosis.
With her innovative surgical techniques and personalized care plans, Dr. Kitano is leading the charge in improving treatment options for those facing peritoneal carcinomatosis.
Overall Dr. Mio Kitano is an inspiring figure who is dedicating her life to finding new ways to treat Gastrointestinal cancer cases like Peritoneal Carcinomatosis ,and her work will continue to have a significant impact on medical practices and patient outcomes in years to come
